| MODULA Modul 7 VRR (NCT00180414) | Boston Scientific Corporation | 2004-08-28 |
| Line Versus Spot Ablation in Persistent Atrial Fibrillation (NCT00196157) | Deutsches Herzzentrum Muenchen | 2004-08-01 |
| Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation (NCT00196183) | Deutsches Herzzentrum Muenchen | 2004-08-01 |
| Safety and Efficacy Study of RENEWAL 4 AVT (NCT00180336) | Boston Scientific Corporation | 2004-07-01 |
| BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status (NCT00779064) | Bayer | 2004-07-01 |
| Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery (NCT00125320) | Astellas Pharma Inc | 2004-06-01 |
| Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter (NCT00115791) | Astellas Pharma Inc | 2004-06-01 |
| Safety Monitoring of Patients Having Pulmonary Vein Ablation (NCT00590668) | The Cleveland Clinic | 2004-05-01 |
| Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation (NCT00315068) | University Hospital, Geneva | 2004-04-01 |
| Diastolic Dysfunction and Atrial Fibrillation in CABG Surgery (NCT00188903) | University Health Network, Toronto | 2004-03-01 |
| Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT) (NCT00289289) | Medtronic Cardiac Rhythm and Heart Failure | 2004-02-01 |
| Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (NCT01678456) | Atrial Fibrillation Network | 2004-02-01 |
| Atrial Fibrillation and the Risk for Neurological Complications (NCT00357227) | University Hospital Muenster | 2004-01-01 |
| Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study) (NCT00287209) | University of Aarhus | 2004-01-01 |
| CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation (NCT00170313) | Medtronic Cardiac Rhythm and Heart Failure | 2003-12-01 |
| Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 (NCT00157248) | Boehringer Ingelheim | 2003-12-01 |
| Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation. (NCT00232245) | Melbourne Health | 2003-12-01 |
| TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics (NCT00279981) | Medtronic Cardiac Rhythm and Heart Failure | 2003-11-01 |
| CONTAK RENEWAL 3 AVT (NCT00158977) | Boston Scientific Corporation | 2003-11-01 |
| PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin (NCT01227629) | Boehringer Ingelheim | 2003-09-01 |
| To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation (NCT00189319) | MEDA Pharma GmbH & Co. KG | 2003-09-01 |
| Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia (NCT00232232) | Melbourne Health | 2003-09-01 |
| Pharmacogenetics and Cardiovascular Events (NCT00094198) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-09-01 |
| Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy (NCT00187252) | Abbott Medical Devices | 2003-09-01 |
| Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) (NCT00070655) | Sanofi | 2003-09-01 |
| Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation (NCT00468767) | Advanz Pharma | 2003-08-01 |
| The Home INR Study (NCT00032591) | US Department of Veterans Affairs | 2003-08-01 |
| Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older (NCT00116987) | University of Calgary | 2003-08-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) (NCT00243178) | Sanofi | 2003-07-01 |
| A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation (NCT00434694) | University of Pennsylvania | 2003-07-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) (NCT00249873) | Sanofi | 2003-06-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) (NCT00249795) | Sanofi | 2003-06-01 |
| SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction (NCT00284830) | Medtronic Cardiac Rhythm and Heart Failure | 2003-01-01 |
| Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion (NCT00232219) | Melbourne Health | 2003-01-01 |
| Ten-year Outcomes After AF Ablation (NCT01867099) | Valley Health System | 2002-12-01 |
| Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation (NCT00272636) | University of Michigan | 2002-11-01 |
| A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation (NCT00192972) | Rigshospitalet, Denmark | 2002-11-01 |
| Comparison of Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing for Patients With Atrial Fibrillation With Congestive Heart Failure (PABA CHF) (NCT00599976) | Azienda Policlinico Umberto I | 2002-11-01 |
| The Effect of Arrhythmia Surgery on Quality of Life in Patients With Atrial Fibrillation Undergoing Cardiac Surgery (NCT00886080) | Maastricht University Medical Center | 2002-10-01 |
| Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study - (NCT00848445) | Boston Scientific Corporation | 2002-10-01 |
| The Value of add-on Arrhythmia Surgery in Patients With Atrial Fibrillation Undergoing Cardiac Surgery (NCT01019759) | Maastricht University Medical Center | 2002-09-01 |
| European Study of Dronedarone in Atrial Fibrillation (NCT00697086) | Sanofi | 2002-08-01 |
| Genetic Determinants of Warfarin Anticoagulation Effect (NCT00162435) | Hadassah Medical Organization | 2002-08-01 |
| FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers (NCT00196144) | Deutsches Herzzentrum Muenchen | 2002-07-01 |
| Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation (NCT01912326) | Abbott Medical Devices | 2002-07-01 |
| Atrial Fibrillation Incidence, Risk Factors and Genetics (NCT00021905) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-07-01 |
| Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation (NCT02626871) | University of Turku | 2002-01-01 |
| Follow up of Radiofrequency Maze in Mitral Patients (NCT02321020) | Centro Cardiologico Monzino | 2002-01-01 |
| Use of Radiofrequency Ablation to Eliminate Continuous Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery (NCT00238706) | University Hospitals, Leicester | 2001-12-01 |
| EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) (NCT00259428) | Sanofi | 2001-11-01 |
| American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm (NCT00259376) | Sanofi | 2001-11-01 |
| Framingham Offspring Study: Psychosocial Risk Factors (NCT00037323) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-05-01 |
| Atrial Fibrillation and Congestive Heart Failure Trial (NCT00597077) | Montreal Heart Institute | 2001-04-01 |
| Candesartan in the Prevention of Relapsing Atrial Fibrillation (NCT00130975) | Asker & Baerum Hospital | 2001-04-01 |
| Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. (NCT00035451) | Forest Laboratories | 2001-02-01 |
| Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation (NCT00209911) | Hvidovre University Hospital | 2001-01-01 |
| To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events (NCT01224574) | Hopital Lariboisière | 2001-01-01 |
| Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation (NCT02832089) | Andhra Medical College | 2000-12-01 |
| S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation (NCT00244426) | Pfizer | 2000-12-01 |
| Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation. (NCT00035464) | Forest Laboratories | 2000-12-01 |
| Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation (NCT00035477) | Forest Laboratories | 2000-09-01 |
| LEAF - Low Energy In Atrial Fibrillation (NCT00157781) | Medtronic Cardiac Rhythm and Heart Failure | 2000-08-01 |
| Identification of Genomic Predictors of Adverse Events After Cardiac Surgery (NCT01258231) | Brigham and Women's Hospital | 2000-08-01 |
| The Atrial High Rate Episodes in Pacemaker Patients (NCT00627328) | Medtronic Cardiac Rhythm and Heart Failure | 2000-07-01 |
| Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist (NCT00075985) | US Department of Veterans Affairs | 2000-05-01 |
| Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (NCT03847753) | University of Aarhus | 2000-01-01 |
| Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) (NCT00289042) | The Cleveland Clinic | 1999-12-01 |
| Atrial Pacing for Termination and Prevention of Atrial Fibrillation (NCT00123344) | University of Calgary | 1999-12-01 |
| Studies of the Prevention of Atrial Fibrillation by ALA (NCT00410839) | University of Toronto | 1999-06-01 |
| Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet (NCT00410020) | Assistance Publique - Hôpitaux de Paris | 1999-06-01 |
| Amiodarone to Prevent Post-Operative Arrhythmias (NCT00251706) | University of Calgary | 1999-02-01 |
| Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm (NCT00007605) | US Department of Veterans Affairs | 1998-04-01 |
| Serum Uric Acid Levels and Onset of Cardiovascular Diseases: a CALIBER Study (NCT03425305) | University College, London | 1998-01-01 |
| Natural History and Patient Journey in Atrial Fibrillation: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals. (NCT04786366) | University College, London | 1998-01-01 |
| Registry of Cardiovascular Disease Patients (NCT01759225) | Maccabi Healthcare Services, Israel | 1998-01-01 |
| Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) (NCT00000556) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-03-01 |
| Essential Hypotension and Allostasis Registry (NCT02018497) | CES University | 1995-01-01 |
| The Study of Men Born in 1943 (NCT03138122) | Sahlgrenska University Hospital | 1993-02-09 |
| Evaluating the Relationship Between Fatty Acids and Heart Disease (NCT00404872) | Brigham and Women's Hospital | 1989-01-01 |
| Epidemiology of Symptomatic Arrhythmias (NCT00005237) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-12-01 |
| Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) (NCT00000517) | Massachusetts General Hospital | 1985-07-01 |
| Follow-up Study of the RAI-Treated Hyperthyroid Patients (NCT00471458) | Tampere University | 1969-01-01 |
| Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. (NCT00408473) | MEDA Pharma GmbH & Co. KG | |
| Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF (NCT00583921) | University of California, Davis | |
| Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes (NCT00173030) | National Taiwan University Hospital | |
| AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB (NCT00571779) | AtriCure, Inc. | |
| Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation (NCT00040001) | Aderis Pharmaceuticals | |
| Pulmonary Vein Isolation Outcomes With Fish Oils (NCT00841451) | St. Luke's-Roosevelt Hospital Center | |
| Change of Heart Rate Variability and Baroreflex Sensitivity After Ventral Cardiac Denervation (NCT00190112) | Far Eastern Memorial Hospital | |
| AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation (NCT00785902) | AtriCure, Inc. | |
| Inflammatory and Fibrotic Markers and Atrial Fibrillation (NCT00173589) | National Taiwan University Hospital | |
| ALA and Prostate Cancer (NCT00309439) | University of Toronto | |